Leaflet FROMENA 2.5mg film-coated tablets
Indicated for: migraine
Route of administration: oral
Substance: frovatriptan (serotonin agonist antimigraine)
ATC: N02CC07 (Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Frovatriptan is a medication used for the treatment of acute migraines, with or without aura. It belongs to a class of drugs known as serotonin receptor agonists (5-HT1), which work by constricting blood vessels in the brain and reducing inflammation associated with migraines. It is effective in relieving pain and other migraine symptoms, such as nausea and sensitivity to light or sound.
Frovatriptan is usually administered in the form of oral tablets, and the dosage is determined by the doctor based on the severity of the migraine and the patient's response to treatment. It is important to take it as soon as possible after the onset of migraine symptoms to maximize its effectiveness.
Common side effects include dizziness, fatigue, a sensation of pressure or pain in the chest, and dry mouth. In rare cases, it may cause more severe reactions, such as increased blood pressure or allergic reactions. Patients with cardiovascular conditions should use this medication with caution.
Frovatriptan is a valuable treatment for migraines, but its use requires strict adherence to the doctor's instructions. It is essential for patients to inform their doctor about any pre-existing conditions or medications they are taking to avoid drug interactions.
General data about FROMENA 2.5mg
- Substance: frovatriptan
- Date of latest medicines list: 01-06-2016
- Product code: W41750002
- Concentration: 2.5mg
- Pharmaceutical form: film-coated tablets
- Quantity: 2
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.